Zr. Liu et al., INDIRECT RECOGNITION OF DONOR HLA-DR PEPTIDES IN ORGAN ALLOGRAFT-REJECTION, The Journal of clinical investigation, 98(5), 1996, pp. 1150-1157
To determine whether indirect allorecognition is involved in heart all
ograft rejection T cells obtained from peripheral blood and graft biop
sy tissues were expanded in the presence of IL-2 and tested in limitin
g dilution analysis (LDA) for reactivity to synthetic peptides corresp
onding to the hypervariable regions of the mismatched HLA-DR antigen(s
) of the donor, Serial studies of 32 patients showed that T cell react
ivity to donor allopeptides was strongly associated with episodes of a
cute rejection. The frequency of allopeptide reactive T cells was 10-5
0-fold higher in the graft than in the periphery indicating that T cel
ls activated via the indirect allorecognition pathway participate acti
vely in acute allograft rejection. In recipients carrying a graft diff
ering by two HLA-DR alleles the response appeared to target only one o
f the mismatched antigens of the donor, Indirect allorecognition was r
estricted by a single HLA-DR antigen of the host and directed against
one immunodominant peptide of donor HLA-DR protein. However, intermole
cular spreading was demonstrated in patients with multiple rejection e
pisodes by showing that they develop allopeptide reactivity against th
e second HLA-DR antigen. These data imply that early treatment to supp
ress T cell responses through the indirect pathway of allorecognition,
such as tolerance induction to the dominant donor determinant, may be
required to prevent amplification and perpetuation of the rejection p
rocess.